DAIC

FEBRUARY 7, 2024

This new document builds off of the previously published Best Practices for Consumer Cardiovascular Technology Solutions in January 2022. Cardiovascular disease is the leading cause of death globally, taking an estimated 695,000 lives in 2021 in the United States, about 1 in every 5 deaths, according to the CDC.

Technology 116

Technology Cardiovascular Disease Best Practices AFIB 116

DAIC

FEBRUARY 28, 2024

The new scientific statement, “Use of Artificial Intelligence in Improving Outcomes in Heart Disease,” comes amid intense attention on AI as a way to improve cardiovascular disease prevention, detection, diagnosis and treatment.

Best Practices 111

Best Practices Technology Cardiovascular Disease Research 111

Circulation: Genomic and Precision Medicine

MAY 23, 2024

This requires an interoperability framework that enables the deployment of platforms, sensors, devices, and software applications within diverse health systems, aiming to facilitate innovation in preventing and treating cardiovascular disease.

Cardiovascular Disease 40

Cardiovascular Disease Best Practices Innovation Circulation 40

Science Daily - Heart Disease

FEBRUARY 27, 2024

Findings of a review of data from three clinical trials challenge current best practice for use of the drug for primary prevention of heart disease or stroke -- otherwise known as atherosclerotic cardiovascular disease.

Heart Disease 62

Heart Disease Best Practices Research Cardiovascular Disease 62

Circulation

FEBRUARY 28, 2024

This scientific statement outlines the current state of the art on the use of artificial intelligence algorithms and data science in the diagnosis, classification, and treatment of cardiovascular disease.

Best Practices 82

Best Practices Heart Disease Outcomes Education 82

DAIC

DECEMBER 9, 2023

However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures.

Webinar 105

Webinar Interventional Cardiology Best Practices Risk Factors 105

DAIC

DECEMBER 9, 2023

However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures.

Webinar 52

Webinar Interventional Cardiology Best Practices Risk Factors 52